Peerbridge Health’s Remote Device for Early Detection of Heart Failure Achieves 95.7% Success Rate in Trial
Low-cost, Patient-friendly Platform Can Improve Patient Outcomes While Reducing Healthcare Spending.
The Cor platform’s advanced ambulatory ECG capabilities transform healthcare, enabling faster, more accurate, and affordable diagnoses that enhance patients’ quality of life.
Only patented 3 lead, 2-channel wireless AECG patch with Einthoven triangle design
Proprietary algorithm to compute derived 12 lead
Explainable AI markers for Hospital Grade Indications (under trial)
Hospital-grade diagnostics and monitoring anywhere, anytime (under trial)
The Peerbridge Cor is the voice of the heart, capturing 31 rhythms with superior recording fidelity, P-wave definition, and QRS morphology.
Early detection and treatment of heart failure can significantly improve patient outcomes and alleviate the strain on healthcare systems. Peerbridge Cor’s innovative remote monitoring solution enables timely and accurate diagnosis, even in asymptomatic individuals, presenting a more accessible and cost-effective approach than traditional methods.
The Peerbridge Cor is quickly becoming a transformative multipurpose diagnostic tool, facilitating early interventions that will enhance the quality of life for our cardiovascular patients
As a physician, the ability to intervene for patients before an emergency visit represents a significant opportunity for patient health. It also allows us to inexpensively expand our care to patients who currently aren’t being reached.
This technology offers significant clinical value to heart failure and cardiac patients throughout their continuum of care, with improved monitoring and treatment of their conditions – whether they are in a clinic, hospital, or at home.
With Peerbridge Cor, physicians can remotely monitor and deliver an accurate heart failure diagnosis within 30 minutes of applying Cor, compared to the current diagnosis timeline of 11-15 weeks with in-hospital screening tools.
Continuous monitoring of a patient’s heart activity while they go about their daily activities outside of a clinical setting.
On-demand diagnostics and screening tools with <10 minutes of wear.
Enabling simplified and accelerated research.
Low-cost, Patient-friendly Platform Can Improve Patient Outcomes While Reducing Healthcare Spending.
Peerbridge Health is pleased to announce the successful completion and findings of its prospective, feasibility clinical trial, resulting in a statistically significant 91.2% predictive accuracy for the determination of apnea-hypopnea index (AHI) for diagnosing obstructive sleep apnea (OSA) while using the Peerbridge Cor.
SADA, a leading business and technology consultancy, and award-winning Google Cloud Premier partner across seven different categories, is collaborating with Peerbridge Health on building its next-generation enterprise clinician portal to scale the deployment of their highly innovative remote cardiac monitoring platform on Google Cloud.